Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ALR's 30-Y Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2017

ALR Guru Trades in Q1 2017

David Einhorn 1,046,697 sh (New)
Jim Simons 493,324 sh (+549.11%)
Jeremy Grantham 899,800 sh (+88.84%)
Diamond Hill Capital 2,424,801 sh (+0.02%)
Leucadia National 40,000 sh (unchged)
Eric Mindich Sold Out
George Soros Sold Out
Private Capital 752,917 sh (-0.81%)
Mario Gabelli 367,120 sh (-3.53%)
Joel Greenblatt 103,912 sh (-15.69%)
First Eagle Investment 1,372,088 sh (-17.50%)
» More
Q2 2017

ALR Guru Trades in Q2 2017

Steven Cohen 24,400 sh (New)
Jim Simons 2,231,924 sh (+352.43%)
Mario Gabelli 509,952 sh (+38.91%)
First Eagle Investment Sold Out
Leucadia National Sold Out
Jeremy Grantham Sold Out
David Einhorn Sold Out
Private Capital 736,260 sh (-2.21%)
Diamond Hill Capital 2,115,775 sh (-12.74%)
Joel Greenblatt 89,070 sh (-14.28%)
» More
Q3 2017

ALR Guru Trades in Q3 2017

Prem Watsa 365,000 sh (New)
Jim Simons 2,253,341 sh (+0.96%)
Steven Cohen Sold Out
Joel Greenblatt Sold Out
Diamond Hill Capital Sold Out
Private Capital 689,285 sh (-6.38%)
Mario Gabelli 454,922 sh (-10.79%)
» More
Q4 2017

ALR Guru Trades in Q4 2017

Private Capital Sold Out
Prem Watsa Sold Out
Jim Simons Sold Out
Mario Gabelli Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with ALR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Private Capital 2017-12-31 Sold Out 5.35%$50.99 - $50.99 $ 50.990%0
Prem Watsa 2017-12-31 Sold Out 1.52%$50.99 - $50.99 $ 50.990%0
Mario Gabelli 2017-12-31 Sold Out 0.14%$50.99 - $50.99 $ 50.990%0
Private Capital 2017-09-30 Reduce -6.38%0.38%$47.5 - $50.74 $ 50.992%689,285
Mario Gabelli 2017-09-30 Reduce -10.79%0.02%$47.5 - $50.74 $ 50.992%454,922
Prem Watsa 2017-09-30 New Buy1.52%$47.5 - $50.74 $ 50.992%365,000
Joel Greenblatt 2017-09-30 Sold Out 0.06%$47.5 - $50.74 $ 50.992%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Alere Inc

ALRPRB.PFD402.002.993 % Conv Perp Pfd Shs Series -B-

Business Description

Industry: Medical Diagnostics & Research » Diagnostics & Research    NAICS: 334516    SIC: 3826
Traded in other countries:IM5.Germany,
Headquarter Location:USA
Alere Inc provides rapid diagnostics at the point of care, with a focus on cardio metabolic disease, infectious disease and toxicology. The Company's business segments are professional diagnostics, consumer diagnostics, and corporate and other.

Alere, Inc. develops rapid point-of-care diagnostic devices in cardiology, infectious disease, toxicology, diabetes, oncology, and women's health. North America accounts for the largest portion of the firm's revenue (55%), followed by Europe (19%), Asia-Pacific (14%), and the rest of the world (12%). Alere's headquarters are in Waltham, Massachusetts.

Top Ranked Articles about Alere Inc

Prem Watsa Trims IBM, Berkshire Hathaway The guru’s largest sales of the 4th quarter
Prem Watsa (Trades, Portfolio), founder, chairman and CEO of Fairfax Financial Holdings,  sold shares of the following stocks during the fourth quarter. Read more...
Mario Gabelli Exits Kite Pharma, Trims Time Warner The guru's largest sales of the 4th quarter
GAMCO Investors leader Mario Gabelli (Trades, Portfolio) sold shares of the following stocks in the fourth quarter. Read more...
3 Investors Sitting on Huge Cash Stockpiles Buffett, Klarman and Watsa
With markets climbing to record highs Tuesday, three investing powerhouses await changes in the market and economy. Warren Buffett (Trades, Portfolio), Seth Klarman (Trades, Portfolio) and Prem Watsa (Trades, Portfolio) each have amassed huge cash stockpiles ready to deploy when better deals emerge. Read more...
Watsa Buys 19 Holdings in What He Calls ‘Stock-Picker’s Market’ Watsa said he's also prepared for a 'hard market' ahead
As many of his peers such as Seth Klarman (Trades, Portfolio) take cover from the heated market, Prem Watsa (Trades, Portfolio) has acquired 19 new positions in the third quarter, selling none of his existing holdings and reducing only three. Read more...
Lifshitz & Miller LLP Announces Investigation of Alere Inc., Emergent BioSolutions, Inc., Frontier Communications Corporation, HSN, Inc., Insys Therapeutics Inc., LSB Industries, Inc. and Otonomy, Inc.
Alere Receives FDA Clearance for Alere™ i Influenza A & B 2 Rapid Molecular Test
Alere Announces the U.S. Department of Justice Closes Investigation
Alere Reaches Settlement With SEC The company will pay $13 million
Alere Inc. (NYSE:ALR) announced Sept. 28 it has settled with the U.S. Securities and Exchange Commission in regard to an investagion of accounting issues concerning the company's foreign subsidiaries. Read more...
Abbott Acquisition of Alere Set to Close on October 3, 2017
Alere Announces Agreement in Principle to Settle with the U.S. Department of Justice



Buy Back


Valuation & Return


More Statistics

Revenue (TTM) (Mil) $2,332.93
EPS (TTM) $ -3.12
52-Week Range $34.41 - 51.00
Shares Outstanding (Mil)87.58

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 2,439 2,501
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) 0.14 0.26
EPS without NRI ($) 0.14 0.26
EPS Growth Rate
(Future 3Y To 5Y Estimate)
Dividends per Share ($) 0.25

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat